Sequential bypass on the beating heart can be achieved without compromising patient safety or regional myocardial

Robert L Quigley1

  • 1Department of Surgery, Jefferson Health System, Philadelphia, Pennsylvania, USA. robert.quigley@internationalsos.com

International Surgery
|November 12, 2010
PubMed

Insights

This study shows that using a sequential reversed saphenous vein graft (rSVG) with an internal mammary artery (IMA) graft for off-pump coronary artery bypass grafting (OPCABG) is safe. This technique effectively revascularizes the heart without compromising blood flow, offering a less invasive option.

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Cardiac Procedures
  • Coronary Artery Bypass Grafting

Background:

  • Off-pump coronary artery bypass grafting (OPCABG) is preferred by some surgeons to minimize aortic manipulation.
  • Sequential reversed saphenous vein grafts (rSVG) offer a method for multi-vessel revascularization with a single aortic anastomosis.

Purpose of the Study:

  • To evaluate the safety and efficacy of combining an internal mammary artery (IMA) graft with a sequential rSVG for OPCABG.
  • To assess distal conduit blood flow in sequential rSVG grafts during OPCABG.

Main Methods:

  • Retrospective review of 175 consecutive OPCABG patients undergoing 1 IMA and 1 sequential rSVG.
  • Flow rates in sequential rSVG segments measured using a Transonic Flowmeter.
  • Patients received postoperative clopidogrel for 6 weeks.

Main Results:

  • Mean distal flow in sequential rSVG was 36 ml/min, unaffected by proximal anastomoses or coronary bed size.
  • Zero 30-day mortality and stroke rates (0/175).
  • Postoperative atrial fibrillation occurred in 29% of patients with normal baseline rhythm; no myocardial infarctions or renal failure requiring dialysis.

Conclusions:

  • The described OPCABG technique using IMA and sequential rSVG is safe and effective.
  • Sequential anastomoses in rSVG do not compromise regional coronary blood flow.
  • This approach represents a viable, less invasive option for complex coronary revascularization.

Related Concept Videos